ketoconazole has been researched along with Bilirubinemia in 2 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernuau, J | 1 |
| Durand, F | 1 |
| Pessayre, D | 1 |
| Benson, GD | 1 |
| Anderson, PK | 1 |
| Combes, B | 1 |
| Ishak, KG | 1 |
2 other studies available for ketoconazole and Bilirubinemia
| Article | Year |
|---|---|
Ketoconazole-induced hepatotoxicity.
Topics: Adult; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Humans; Hy | 1997 |
Prolonged jaundice following ketoconazole-induced hepatic injury.
Topics: Adult; Biopsy; Cholestasis; Humans; Hyperbilirubinemia; Ketoconazole; Liver; Male; Middle Aged; Pred | 1988 |